Form D — ASCENDIA PHARMACEUTICALS, INC.
0001855888-26-000005 · filed Jul 24, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Other Health Care filings
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Reported offering amount
- $4,084,536
- Reported amount sold
- $4,084,536
- Minimum investment
- $500,000
- Investors
- 3
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- ASCENDIA PHARMACEUTICALS, INC.
- CIK
- 1855888
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 661 US HIGHWAY ONE
NORTH BRUNSWICK, NJ 08902 - Phone
- 7326400058
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jingjun Huang · DirectorNorth Brunswick, NJ Find on LinkedIn ↗
-
Michael Bogda · DirectorNorth Brunswick, NJ Find on LinkedIn ↗
-
James Gale · DirectorNorth Brunswick, NJ Find on LinkedIn ↗
-
Robert Bloder · DirectorNorth Brunswick, NJ Find on LinkedIn ↗
-
Theron Odlaug · DirectorNorth Brunswick, NJ Find on LinkedIn ↗
-
Shoufeng Li · DirectorNorth Brunswick, NJ Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗